174 related articles for article (PubMed ID: 12217749)
1. Malignant ascites fluid (MAF), including ovarian-cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis.
Richardson M; Gunawan J; Hatton MW; Seidlitz E; Hirte HW; Singh G
Gynecol Oncol; 2002 Sep; 86(3):279-87. PubMed ID: 12217749
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity determination of human angiostatin (k1-3) in culture cells and larvae of silkworm.
Wang YF; Jin YF; Zhang YZ
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):482-7. PubMed ID: 12098772
[TBL] [Abstract][Full Text] [Related]
3. Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property.
Jandu N; Richardson M; Singh G; Hirte H; Hatton MW
Int J Gynecol Cancer; 2006; 16(4):1536-44. PubMed ID: 16884362
[TBL] [Abstract][Full Text] [Related]
4. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
[TBL] [Abstract][Full Text] [Related]
5. A novel assay of angiogenesis in the quail chorioallantoic membrane: stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection.
Parsons-Wingerter P; Lwai B; Yang MC; Elliott KE; Milaninia A; Redlitz A; Clark JI; Sage EH
Microvasc Res; 1998 May; 55(3):201-14. PubMed ID: 9657920
[TBL] [Abstract][Full Text] [Related]
6. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA
J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382
[TBL] [Abstract][Full Text] [Related]
7. Angiostatin expression in endometrial cancer.
Yabushita H; Noguchi M; Kinoshita S; Kishida T; Sawaguchi K; Noguchi M
Oncol Rep; 2002; 9(6):1193-6. PubMed ID: 12375018
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel.
Celletti FL; Waugh JM; Amabile PG; Kao EY; Boroumand S; Dake MD
J Vasc Interv Radiol; 2002 Jul; 13(7):703-7. PubMed ID: 12119329
[TBL] [Abstract][Full Text] [Related]
9. Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent.
Seidlitz E; Korbie D; Marien L; Richardson M; Singh G
Microvasc Res; 2004 Mar; 67(2):105-16. PubMed ID: 15020201
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM
Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189
[TBL] [Abstract][Full Text] [Related]
11. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
[TBL] [Abstract][Full Text] [Related]
12. VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane.
Wilting J; Birkenhäger R; Eichmann A; Kurz H; Martiny-Baron G; Marmé D; McCarthy JE; Christ B; Weich HA
Dev Biol; 1996 May; 176(1):76-85. PubMed ID: 8654896
[TBL] [Abstract][Full Text] [Related]
13. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.
Eriksson K; Magnusson P; Dixelius J; Claesson-Welsh L; Cross MJ
FEBS Lett; 2003 Feb; 536(1-3):19-24. PubMed ID: 12586331
[TBL] [Abstract][Full Text] [Related]
14. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization.
Sack RA; Beaton AR; Sathe S
Curr Eye Res; 1999 Mar; 18(3):186-93. PubMed ID: 10342373
[TBL] [Abstract][Full Text] [Related]
15. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
Xu R; Sun X; Tse LY; Li H; Chan PC; Xu S; Xiao W; Kung HF; Krissansen GW; Fan ST
Hepatology; 2003 Jun; 37(6):1451-60. PubMed ID: 12774025
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of rabbit angiostatin glycoforms I and II in rabbits: angiostatin-I leaves the intravascular space faster and appears to have greater anti-angiogenic activity than angiostatin-II.
Hatton MW; Day S; Southward SM; Dereske M; Ross B; Seidlitz E; Singh G; Richardson M
J Lab Clin Med; 2001 Aug; 138(2):83-93. PubMed ID: 11477374
[TBL] [Abstract][Full Text] [Related]
18. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen.
Falcone DJ; Khan KM; Layne T; Fernandes L
J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061
[TBL] [Abstract][Full Text] [Related]
19. Direct binding of recombinant plasminogen kringle 1-3 to angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAM.
Youn MR; Park MH; Choi CK; Ahn BC; Kim HY; Kang SS; Hong YK; Joe YA; Kim JS; You WK; Lee HS; Chung SI; Chang SI
Biochem Biophys Res Commun; 2006 May; 343(3):917-23. PubMed ID: 16564503
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
